Hims & Hers Shares Jump After Novo Nordisk Partnership, Multiple Analyst Upgrades
Hims & Hers stock rallied further on Tuesday after a strategic collaboration with Novo Nordisk enabled the company to sell commercially available Ozempic and Wegovy products, including an upcoming pill form, and prompted several analyst upgrades. Novo Nordisk also withdrew its lawsuit against Hims & Hers, decreasing legal uncertainty. Brokerages ra…